Cargando…
Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors
Prostate cancer (PCa) is a heterogeneous group of tumors with variable clinical courses. In order to improve patient outcomes, it is critical to clinically separate aggressive PCa (AG) from non-aggressive PCa (NAG). Although recent genomic studies have identified a spectrum of molecular abnormalitie...
Autores principales: | Li, Qing Kay, Chen, Jing, Hu, Yingwei, Höti, Naseruddin, Lih, Tung-Shing Mamie, Thomas, Stefani N., Chen, Li, Roy, Sujayita, Meeker, Alan, Shah, Punit, Chen, Lijun, Bova, G. Steven, Zhang, Bai, Zhang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460832/ https://www.ncbi.nlm.nih.gov/pubmed/34556748 http://dx.doi.org/10.1038/s41598-021-98410-0 |
Ejemplares similares
-
Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA
por: Wang, Ce, et al.
Publicado: (2019) -
Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023) -
Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
por: Zhou, Yangying, et al.
Publicado: (2020) -
Urinary glycoproteins associated with aggressive prostate cancer
por: Dong, Mingming, et al.
Publicado: (2020) -
Aggressive Metastatic GATA3-Positive Sarcomatoid Carcinoma with Rapid Progression and Invasion of the Liver
por: Shaukat, Irfan, et al.
Publicado: (2018)